771 Seven-Day Rifabutin Containing Triple Therapy Versus Seven-Day Levofloxacin Containing Quadruple Therapy As Second-Line Treatment for Helicobacter pylori in Chinese Patients: An Open Label, Randomized Trial

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2006.02764.x ◽

2006 ◽

Vol 23 (3) ◽

pp. 421-427 ◽

Cited By ~ 45

Author(s):

W. M. WONG ◽

Q. GU ◽

K.-M. CHU ◽

Y. K. YEE ◽

F. M. Y. FUNG ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

Second Line ◽

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2003.01676.x ◽

2003 ◽

Vol 18 (6) ◽

pp. 627-633 ◽

Cited By ~ 72

Author(s):

E. C. Nista ◽

M. Candelli ◽

F. Cremonini ◽

I. A. Cazzato ◽

S. Di Caro ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Second Line ◽

Quadruple Therapy ◽

Helicobacter Pylori Treatment

Sa1904 Efficacy of 7-Day and 14-Day Moxifloxacin-Based Triple Therapy Versus 7-Day and 14-Day Bismuth-Containing Quadruple Therapy As Second-Line Treatment for Helicobacter pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(13)61213-5 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-331 ◽

Cited By ~ 1

Author(s):

Seong tae Lee ◽

Dong Ho Lee ◽

Nayoung Kim ◽

Young Su Park ◽

Cheol Min Shin ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

Second Line ◽

Second-Line Treatment for Helicobacter pylori Infection: 10-day Moxifloxacin-Based Triple Therapy versus 2-week Quadruple Therapy

Helicobacter ◽

10.1111/j.1523-5378.2007.00548.x ◽

2007 ◽

Vol 12 (6) ◽

pp. 623-628 ◽

Cited By ~ 38

Author(s):

Jung Mook Kang ◽

Nayoung Kim ◽

Dong Ho Lee ◽

Young Soo Park ◽

Yu Rim Kim ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

Second Line ◽

Su1695 Levofloxacin, Metronidazole and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second Line Treatment of Helicobacter pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(12)61838-1 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-483 ◽

Cited By ~ 1

Author(s):

Ji Yoon Moon ◽

Gwang Ha Kim ◽

Mun Ki Choi ◽

Bong Eun Lee ◽

Chul Soo Song ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

Second Line ◽

A Multicenter, Open-Label, Randomized Trial of Vonoprazan Versus PPI Based 7-Day Triple Therapy for the First-Line Treatment of Helicobacter Pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(17)31131-9 ◽

2017 ◽

Vol 152 (5) ◽

pp. S250

Author(s):

Soichiro Sue ◽

Hirohumi Kuwashima ◽

Isao Arima ◽

Marina Ogushi ◽

Satoshi Nakao ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

First Line Treatment

Modified Sequential Therapy Containing Levofloxacin Versus Levofloxacin Triple Therapy in the Second Line Treatment of Helicobacter pylori: A Randomized Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2015.04.038 ◽

2015 ◽

Vol 13 (7) ◽

pp. 1384 ◽

Cited By ~ 1

Author(s):

Jyh-ming Liou ◽

Ming-Shiang Wu ◽

C.C. Chen ◽

C.Y. Chang ◽

Y.J. Fang ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Sequential Therapy ◽

Line Treatment ◽

Second Line

Sequential Therapy for 10 Days Versus Triple Therapy for 14 Days in the First-line Treatment of Helicobacter pylori Infection— A Multicenter, Open-label, Randomized Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2013.09.043 ◽

2014 ◽

Vol 12 (1) ◽

pp. 161-162 ◽

Cited By ~ 2

Author(s):

Jyh-Ming Liou ◽

Chieh-Chang Chen ◽

Chi-Yang Chang ◽

Jeng-Yi Wu ◽

You-Jen Fang ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Sequential Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

First Line Treatment

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial

The American Journal of Gastroenterology ◽

10.1038/ajg.2017.195 ◽

2017 ◽

Vol 112 (9) ◽

pp. 1374-1381 ◽

Cited By ~ 14

Author(s):

Ping-I Hsu ◽

Feng-Woei Tsai ◽

Sung-Shuo Kao ◽

Wen-Hung Hsu ◽

Jin-Shiung Cheng ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Triple Therapy ◽

Proton Pump ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Randomized Controlled

Su1190 Berberine-,Allicin-or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial

Gastroenterology ◽

10.1016/s0016-5085(14)61437-2 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-398 ◽

Cited By ~ 4

Author(s):

Xiaomei Zhang ◽

Yunsheng Yang ◽

Sun Gang ◽

Chao Yang ◽

Mingliang Lu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

First Line Treatment